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The gap
Of evolutionary biology’s many practical applications,
those in medicine are the most obvious and potentially
the most important. So far, however, medicine, nursing
and public health have made use of only a fraction of
what evolution has to offer. The magnitude of the gap is
impressive. Studies of medical education found that most
medical schools in the UK and the USA have not one evo-
lutionary biologist on the faculty (Nesse and Schiffman
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Abstract
Evolutionary biology is an essential basic science for medicine, but few doctors
and medical researchers are familiar with its most relevant principles. Most
medical schools have geneticists who understand evolution, but few have even
one evolutionary biologist to suggest other possible applications. The canyon
between evolutionary biology and medicine is wide. The question is whether
they offer each other enough to make bridge building worthwhile. What bene-
ﬁts could be expected if evolution were brought fully to bear on the problems
of medicine? How would studying medical problems advance evolutionary
research? Do doctors need to learn evolution, or is it valuable mainly for
researchers? What practical steps will promote the application of evolutionary
biology in the areas of medicine where it offers the most?
To address these questions, we review current and potential applications of
evolutionary biology to medicine and public health. Some evolutionary tech-
nologies, such as population genetics, serial transfer production of live vaccines,
and phylogenetic analysis, have been widely applied. Other areas, such as infec-
tious disease and aging research, illustrate the dramatic recent progress made
possible by evolutionary insights. In still other areas, such as epidemiology,
psychiatry, and understanding the regulation of bodily defenses, applying evo-
lutionary principles remains an open opportunity. In addition to the utility of
speciﬁc applications, an evolutionary perspective fundamentally challenges the
prevalent but fundamentally incorrect metaphor of the body as a machine
designed by an engineer. Bodies are vulnerable to disease – and remarkably
resilient – precisely because they are not machines built from a plan. They are,
instead, bundles of compromises shaped by natural selection in small incre-
ments to maximize reproduction, not health. Understanding the body as a
product of natural selection, not design, offers new research questions and a
framework for making medical education more coherent. We conclude with
recommendations for actions that would better connect evolutionary biology
and medicine in ways that will beneﬁt public health. It is our hope that faculty
and students will send this article to their undergraduate and medical school
Deans, and that this will initiate discussions about the gap, the great opportu-
nity, and action plans to bring the full power of evolutionary biology to bear
on human health problems.
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do not even accept the theory of evolution (Downie
2004). Most medical students get two or more years of
basic science education, including embryology, biochemis-
try, anatomy, histology, and physiology, and many get a
genetics course from a professor who knows evolutionary
biology. However, we know of no medical school that
teaches a course in evolutionary biology as a basic medi-
cal science, and none that requires evolution as a prerequi-
site. Our teaching experience conﬁrms that few doctors
have a chance to learn the principles of evolutionary biol-
ogy most useful for medicine.
Are medical research and evolutionary biology better
connected? New quantitative evidence comes from an
innovative strategy for mapping citation patterns. Instead
of measuring co-citations between traditionally deﬁned
ﬁelds, Rosvall and Bergstrom (2007) deﬁne the bound-
aries of disciplines empirically from citation patterns.
They then analyze the directed ﬂow of citations between
disciplines. The results for evolution and medicine are
striking (See Fig. 1). Ecology and evolution journals cite
work in medical journals occasionally, but medical jour-
nals cite work in ecology/evolution journals too rarely to
even show up on the diagram. Almost all of the connec-
tions have other ﬁelds as intermediaries.
There are good historical reasons for the gulf between
evolution and medicine (Zampieri 2006). They stem
partly from the timing of Flexner’s (1910) report that rec-
ommended bringing basic sciences into the medical cur-
riculum. At that time, evolutionary biology was in eclipse.
Many scientists thought that Lord Kelvin’s arguments
about the rate of the earth’s cooling proved Darwin
wrong (Kelvin 1862). Others recognized that Darwin’s
theory of transmission by gemmules was inconsistent with
his theory of natural selection (Richards 1987). Natural
selection was not re-incorporated into biology until its
underpinnings in population genetics were developed in
the early to middle years of the 20th century (Fisher
1930). Even then, those foundations emphasized muta-
tions and genetic variations, not the shaping of complex
adaptations by selection, a ﬁeld that was only developed
by evolutionary and behavioral ecologists in the 1970s
and later. Those insights into trait evolution are just now
being incorporated into medical science.
Mastering medicine is increasingly difﬁcult. It includes
far too much knowledge for any one person to learn: on
this educators – and medical students! – agree. The chal-
lenge is to instill as much useful knowledge as possible in
just a few years. The criterion of ‘useful’ is prioritized
because medicine is a practical profession. Patients want
help and doctors need to know what to do. If a deeper
understanding of a disease is useful, ﬁne. Otherwise, there
is no time.
Every discipline makes recommendations, even
demands, for curriculum content. In addition to the usual
20 or so departments in a medical school, there are
demands from groups representing geriatrics, statistics,
gender issues, bio-informatics, nutrition, musculoskeletal
Figure 1 Citation patterns (Rosvall and Bergstrom 2007).
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experts, among scores of others. Each advocates for
including more content in one area. Put them all together
and medical school would take decades.
Interestingly, proposals for curriculum reform tend not
to emphasize ways to include more and more speciﬁc
content. Instead, a review of 24 proposals for medical
curriculum reform found that they consistently focused
on values, especially the social nature and self-regulation
of the medical profession (Christakis 1995). Somehow,
from all of these jostling interest groups, priorities and
multiple regulations and examination requirements, a
Dean and faculty must come up with a curriculum. This
makes it difﬁcult to warmly welcome visitors who drop
by to point out that a whole huge area of basic science
has been omitted from the curriculum. However, evolu-
tionary biology is not just another narrow topic, but a
fundamental basic science. Furthermore, it can help make
medical education more coherent by giving students a
framework for organizing the required 10 000 facts.
Understanding the gap also requires consideration of
how well-prepared evolutionary biologists are to apply
their knowledge to the problems of medicine. Most evo-
lutionary biologists know as little about medicine as phy-
sicians know about evolution. If you cannot tell a
myocardial infarction from cardiac failure, doctors will
not pay attention. If they feel you are just adding to the
thousands of facts they need to memorize, they will ﬂee.
Not many evolutionary biologists are eager to teach medi-
cal students; the best are working hard on their own
research. The gulf will be understood only by looking
from both ends of this two-way street.
Before we consider opportunities and solutions, it is
worth noting that medicine’s isolation from evolutionary
biology is just one example of the fragmentation that iso-
lates many disciplines. Some of the isolation results from
academic structures that allow hiring and promotion to
be controlled by narrow disciplines. Universities talk a lot
about promoting interdisciplinary work precisely because
their structures so efﬁciently prevent it. However, disci-
plines exist for good reasons. There is too much to know.
Trying to synthesize work from diverse areas is frustrat-
ing, especially if the goal is general understanding, not
some ﬁne point. Also, going beyond your specialty means
you will inevitably get some things wrong. It is easier to
maintain quality by keeping to a narrow focus.
Perhaps this list of problems will lead some readers to
throw up their hands. We highlight the problems because
we want decision makers to recognize that we are fully
aware of them. Acknowledging problems allows realistic
solutions. We want also to emphasize that even large
challenges are worth confronting because of the great
beneﬁts of bringing more evolution to medicine.
Most of this article is devoted to examples of rapid
progress in applying evolutionary principles to medicine.
Overviews of evolutionary approaches to health and dis-
ease are available in several articles and books (Williams
and Nesse 1991; Nesse and Williams 1994; Stearns 1998;
Trevathan et al. 1999; Stearns and Koella 2007; Trevathan
2008; O’Higgins and Elton in press), and a critical review
assesses progress and directions (Stearns and Ebert 2001).
The goal here is not to summarize recent work, but to
step back to describe the structure of the developing ﬁeld,
the challenges it faces, and its potential.
The examples are organized into three categories. Some
use well-established applications, some are new, and some
remain mostly opportunities. They suggest actions that
will allow evolutionary biology to provide maximum ben-
eﬁts to human health.
New questions
At the core of evolutionary medicine is recognition that
diseases need both proximate explanations of bodily
mechanisms and evolutionary explanations of why natural
selection has left the body vulnerable to disease. Why do
we have an appendix and wisdom teeth, a narrow birth
canal, arteries prone to atherosclerotic blockage, and cells
that can divide out of control? These are good evolution-
ary questions; they are fundamentally different from
proximate questions.
The distinction between evolutionary and proximate
questions was emphasized by Mayr (1982), but it was
Tinbergen’s (1963) article that outlined the four questions
that must be answered to provide a full explanation for
any biological trait.
Tinbergen’s four questions
Proximate questions
1. How does the mechanism work?
2. What is the ontogeny of the mechanism?
Evolutionary questions
3. How has this mechanism given a selective advantage?
4. What is the phylogeny of this mechanism?
The ﬁrst two questions are about the body’s proximate
mechanisms, from DNA transcription and physiological
regulation to bones, muscles and behavior. The third and
fourth are evolutionary questions about how the body got
to be the way it is. The four questions are complementary
not competing. All four need to be answered for each
trait. Medical textbooks address question 1 in detail,
question 2 sometimes; questions 3 and 4 only rarely.
From this perspective, medicine has been using only one
half of biology.
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Understanding jaundice illustrates why both proximate
and evolutionary explanations are essential. The yellow
color in the skin and eyes is caused by excess bilirubin
that accumulates most often because of liver failure. Text-
books describe bilirubin as a potentially toxic metabolite
of hemoglobin that can be excreted in bile only after it is
made water soluble by conjugation with glucuronic acid
in the liver. This is a proximate explanation that says
nothing about why bilirubin exists in the ﬁrst place. One
might think it is simply a waste product. However, the
intermediate step between heme and bilirubin is biliver-
din, a chemical that is more soluble than bilirubin. So,
why does the body go to the trouble to make a difﬁcult-
to-excrete toxin? This is the evolutionary question.
Bilirubin is an effective antioxidant that can protect
against the oxidative damage that contributes to aging
(Stocker et al. 1987; Nesse and Williams 1994). Oxidative
damage is partially responsible for atherosclerosis, so many
studies have looked to see if higher levels of bilirubin pro-
tect against heart attacks. They do, dramatically. Levels of
bilirubin higher than normal are characteristic in Gilbert’s
disease; middle-aged people with this genetic condition
have rates of heart disease sixfold lower than those with
normal bilirubin levels (Vitek et al. 2002). However, there
is no mention of evolution or natural selection in the arti-
cle that reviews the 11 studies of bilirubin protection
against atherosclerosis (Novotny and Vitek 2003).
An evolutionary perspective suggested an experiment –
looking to see what happens if you knock out the enzyme
that converts biliverdin to bilirubin. When the enzyme is
working, potentially damaging oxygen radicals react with
bilirubin, turning it into biliverdin, thus reducing the
concentration of dangerous peroxide radicals up to
10 000-fold. Without protection by bilirubin cells die
quickly (Snyder and Baranano 2001; Sedlak and Snyder
2004).
This is a ﬁne example of using the details of a proxi-
mate mechanism to test an evolutionary hypothesis.
However, many relevant studies remain to be performed.
No comparative study has investigated bilirubin levels in
other primates to see if they are correlated with life span.
More practically, researchers are now considering whether
there could be possible disadvantages of using light expo-
sure to reduce mildly elevated bilirubin levels in newborn
infants (Hammerman et al. 1998). High bilirubin levels in
the ﬁrst days of life could be merely a result of the
changeover to adult hemoglobin, but they could also help
protect against oxidative damage from higher levels of
oxygen and free iron exposure. The decision is delicate
because too much bilirubin in the early days of life causes
irreversible damage.
Practical applications
When they ﬁrst hear about evolutionary medicine, most
doctors ask immediately, ‘How can I apply it in the clinic
today?’ This surprises many basic scientists, who expect
doctors to share the depth of their curiosity about why
the body is the way it is. However, medicine is not a sci-
ence, it is a practical profession. Patients bring their prob-
lems; doctors try to help. The question, ‘Why has natural
selection left the body so vulnerable to this disease?’
seems very abstract to doctors who need to know right
now, ‘What is the problem? What treatment is best?’
In response to doctors’ demands for practical applica-
tions, it is tempting to offer quick examples of how evo-
lution can inform everyday medical practice. This article
reviews many: preventing antibiotic resistance, the bene-
ﬁts of inﬂammation, the costs of blocking normal
defenses, the phylogeny of HIV, etc. However, offering
examples too quickly creates two problems.
First, even in these practical examples, evolutionary
knowledge does not often change what a physician does
in his or her day-to-day practice; instead, it guides
research, as in the example of jaundice. Treatment deci-
sions are, and should be, based on controlled studies on
humans, not on theory or on experiments performed on
model organisms alone. Darwinian medicine does not
often give direct practice guidelines.
Second, merely listing quick applications sells evolution-
ary biology short. Medical professionals learn other basic
sciences not because they are useful everyday in the clinic,
but because they provide a crucial depth of understanding
and a framework for organizing the myriad facts in which
the mind otherwise drowns. Knowing the mechanisms and
laws of acid–base balance gives a physician the perspective
needed to apply formulas in the clinic. Evolutionary biol-
ogy offers the same sort of help, but on a much larger scale.
Instead of phenomena as speciﬁc as acid–base balance,
evolution helps doctors make sense of why a disease exists
at all, what environments increase the risk, and how treat-
ments work. It has direct applications to medical research,
but it also provides an otherwise missing paradigm for
understanding why our bodies are vulnerable to disease.
A framework
While no framework can capture all of the applications
of evolution to medicine, recognizing two major distinc-
tions is helpful. Table 1 shows the categories created by
intersecting the two different evolutionary questions with
a selection of things that need explanation.
It is important to distinguish the two different kinds
of evolutionary questions. Answers to questions about
phylogeny trace the evolutionary history of the trait in
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cance of a trait try to understand why a trait is in the
state we ﬁnd it. Historical and adaptive approaches use
different methods to test hypotheses; both can deliver
usefully different insights, often on the same issues.
The other distinction is among the different things we
want to explain. Often the question is about why our
bodies are the way they are, especially why selection has left
us vulnerable to a disease. The object of explanation can be
a universal trait, such as bilirubin, or it can be traits that
differ, for instance, versions of certain genes. For instance,
some people have versions of genes that increase depression
rates (Caspi et al. 2003; Sen et al. 2003); why has selection
not eliminated these alleles? Many questions are about why
all humans are all the same; many are about why we differ.
The second major target of explanation is the evolution
of pathogens – bacteria, viruses, worms and others. The
large issues are the same, but they evolve much faster, so
we can often observe their evolution, even in the labora-
tory where this allows experimental tests of hypotheses.
Another target for explanation is the evolution of cells
within the body, particularly cancer cells and certain clas-
ses of cells in the immune system. Cancer originates
through mutation. Cells that divide faster and better
evade the body’s surveillance systems become more com-
mon and spread: a standard evolutionary process. Cells in
the immune system also undergo a kind of evolution so
that those that most effectively ﬁght an infection multiply
the most quickly. In both cases selection is not acting on
organisms, but on cell lines within individuals; here too
evolutionary principles can be useful.
Well-established applications
The applications of evolution to medicine divide naturally
according to the types of questions asked. Because
Table 1. Categories of evolutionary questions.
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icance require different methods and different skills, it is
not surprising that these areas of research remain some-
what separate in evolutionary medicine.
Phylogenetic methods
Some of the most useful applications of evolution often
do not use evolutionary theory directly; instead they use
technologies developed by evolutionary biologists. In par-
ticular, methods for reconstructing phylogenies are being
applied to genetic data with very practical results. HIV is
especially susceptible to such methods because its fast-
accumulating mutations create ﬁnely detailed phylogenies.
For instance, certain cases of HIV could be traced back to
a speciﬁc Florida dentist (Ciesielski et al. 1992). Phyloge-
netic analysis also was used to falsify the hypothesis that
HIV was introduced into Africa via polio vaccine (Weiss
2001). The SARS epidemic was traced quickly to a corona
virus similar to one endemic in bats (Li et al. 2004;
Skowronski et al. 2005).
Tracing pathogen phylogenies can be very useful. Inﬂu-
enza phylogenies suggest which strains are likely to spread
in future epidemics (Bush et al. 1999; Ghedin et al. 2005;
Smith 2006), information vital to decisions about vaccine
design. The current H5N1 avian inﬂuenza pandemic
appears to have originated via reassortment between avian
inﬂuenza strains circulating in eastern Asia (Li et al. 2004).
Public health now uses such methods routinely to trace
the source of contaminated foods. These phylogenetic
methods have a remarkable reach, back even into prehis-
tory. For instance, the complete genome sequence of the
severely pathogenic Shigella ﬂexneri reveals that it is phy-
logenetically indistinguishable from the Escherichia coli
that lives normally in the human gut (Wei et al. 2003).
The difference seems to be in a few virulence factors that
result in substantially different ecological niches for the
two organisms.
Technologies for tracing phylogenies have ready appli-
cation to antibiotic resistance and to pathogen evolution
in general. They are particularly powerful in revealing the
origins of emerging diseases. For example, HIV1 origi-
nated in chimpanzees in Central Africa, and HIV2 origi-
nated in sooty mangabeys in West Africa (Heeney et al.
2006). Importantly, these species do not develop AIDS.
Phylogenetic methods have also found recent applica-
tions in cancer research and treatment. Cell lines differenti-
ate as mutations accumulate, and the genetic differences
make it possible to trace the sequence. Two tumors that are
histologically identical can have very different proteonomic
signatures that make it possible to assess the level of cellu-
lar differentiation (Abu-Asab et al. 2006). Whether a tumor
is all derived from the one line of cells, or from different
origins arising during the tumor’s growth may also be an
important indicator (Merlo et al. 2006; Frank 2007).
Researchers in every area of medicine use phylogenetic
methods to analyze genetic data. Sometimes they are used
in conjunction with evolutionary theory, but they are also
used independently to construct phylogenies with new
applications in an era of genetic medicine. Doctors who
understand these phylogenetic methods and the evolu-
tionary biology behind them will be better prepared to
judge the signiﬁcance of research ﬁndings such as those
summarized above.
Population genetics
As most readers know, evolutionary biology took off only
after it was synthesized with population genetics in the
1920s and 1930’s (Fisher 1930). Mathematical treatments
of allele frequencies that incorporated selection, drift,
mutation, and migration made it possible to begin to
understand the forces that shaped the genome. As Lewon-
tin (1974) has noted, however, this theory developed
separately from breeder’s theories about selection for
phenotypes; the task of mapping changes in allele frequency
to changes in phenotype remains a challenge. While this
gap remains substantial in much of medicine, it is being
reduced by the explosion of work on quantitative trait
loci (QTLs) and single nucleotide polymorphisms (SNPs),
e.g., the Wellcome Trust Case Control Consortium (2007).
The explosion of genetic information tends to focus
attention on genetic differences between individuals. Much
research is trying to explain these differences and their sig-
niﬁcance. An increasing proportion of this work looks for
evolutionary explanations. Relatively overlooked, however,
are questions about why all members of a species are the
same. This is especially important with regards to traits
that leave a species vulnerable to disease, such as wisdom
teeth, the appendix, or a narrow birth canal. Such traits
are also in need of evolutionary explanations, and infor-
mation on genetic variations is not always helpful.
Many physicians think of genes that cause disease as
abnormalities in an otherwise ‘normal’ genome. This is a
nonevolutionary view on two counts. First, it tacitly views
the genome as a product of design with a blueprint that
deﬁnes ‘normal.’ The genome is, instead, a collection of
those genes that have tended to increase reproductive suc-
cess (or hitchhiked on the success of other genes) while
interacting with each other and the environment to con-
struct a functional organism. Second, while some DNA
sequences can be accurately described as ‘damaged’, it is
increasingly clear that many medically relevant genetic
variations are helpful or harmful only in interaction with
particular aspects of environments. Such genes have been
called ‘quirks’ to distinguish them from defective genes
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Williams 1994). For instance, if you have the genes for
nearsightedness, you will almost certainly become near-
sighted. Unless, that is, you live in a culture where
children are not taught to read (Norn 1997). The
problem comes only when certain genes and certain
environments interact. Similarly, some genes that interact
with high fat diets to cause atherosclerosis are quirks that
would be harmless if we lived and ate the way people did
thousands of years ago.
Like phylogenetics, population genetics is a mature
technology already applied widely and effectively through-
out medicine. There are new applications, and one could
quibble about whether users of these methods are think-
ing in evolutionary terms or just using technologies that
work. Nonetheless, population genetics cannot be sepa-
rated from evolutionary theory and, as such, is a well-
established area evolutionary medicine.
Areas of rapid recent progress
New applications of evolutionary principles have brought
spectacular progress in several areas of medicine during
the past 20 years (Stearns and Ebert 2001). Studies of
infectious disease and aging have been especially trans-
formed. For the sake of continuity, however, we begin
with progress coming from increasingly sophisticated evo-
lutionary genetics (Maynard Smith 1998; Jobling et al.
2004).
Evolutionary genetics
Established principles of population genetics are being
augmented by new ideas and techniques. Especially inter-
esting are new strategies for using ‘signals of selection’ to
determine which genes have been strongly selected in the
past few thousand generations. Just a few years ago, this
approach offered a few methods and a few examples
(Olson 2002). Now, many new methods are applied to
genome scan data to identify loci subject to directional
and balancing selection as revealed by the homogeneity of
the DNA sequences surrounding the loci in question
(Vallender and Lahn 2004; Sabeti et al. 2006; Voight et al.
2006), and early overestimates of the number of loci of
interest are now being corrected (Thornton and Jensen
2007).
These methods provide answers to long-standing ques-
tions, such as the origins of genes for lactase persistence
(Bersaglieri et al. 2004). Most adult humans cannot digest
milk because the enzyme that breaks down milk sugar is
not made in adulthood. Recent studies showed that genes
that allow adults to digest milk have evolved separately
several times, almost always in dairying cultures (Holden
and Mace 1997; Ingram et al. 2007; Tishkoff et al. 2007).
Similarly, there has been speculation for decades about
whether the genetic tendency to feel sick immediately
after drinking alcohol could be common in people from
Asia because it protects against alcoholism in a culture
where alcohol has long been available. Evidence has been
sparse until now. The case has been bolstered by ﬁnding
a strong signal of selection in Asians at the site of the
gene (Voight et al. 2006).
The evolutionary backgrounds of alleles that predispose
to disease can now be examined. Of particular interest is
a gene that makes apolipoproteins, substances that bind
and transport lipids. Individuals with the ApoE4 subtype
have a much higher risk of developing atherosclerosis
and Alzheimer’s disease. This allele is universal in other
primates. In humans, especially those living in cold
climates, selection has increased the rates of the ApoE3
allele (Sapolsky and Finch 2000). This may be a case of
selection caught in action, perhaps for genes that prevent
health problems for meat eaters (Finch and Stanford
2004).
Selection has also been proposed as an explanation
for cystic ﬁbrosis, given the scores of mutations that
can cause it and its systematic variation with latitude.
Mice heterozygous for the CF allele have less ﬂuid loss
from cholera toxin (Gabriel et al. 1994), but the chlo-
ride channel is not the rate limiting step for ﬂuid loss
in humans (Hogenauer et al. 2000). The CF gene also
prevents entrance of salmonella typhus into gastrointes-
tinal mucosal cells (Pier et al. 1998). However, cystic
ﬁbrosis is more common in climates where diarrheal
diseases are less common, and although remarkably pre-
valent, it remains a rare allele. Cystic ﬁbrosis offers a
ﬁne example of creative tests of interesting hypotheses,
and an example of how hard it can be to reach a ﬁrm
conclusion about the adaptive signiﬁcance of a genetic
variation.
Until recently, agreement on how to assess the role of
selection on vulnerability genes was elusive (Chadwick
and Cardew 1996). That is changing fast. We now have
systematic reviews of the role of selection in maintaining
the prevalence of genes that increase risk for infectious
disease (Dean et al. 2002), and progress in related areas is
on the way.
Genetic conﬂicts
Naı ¨ve thinking that genes exist always for the good of the
individual and the species remain common in medicine
even though biologists abandoned them in the 1970s. The
importance of gene-level selection is highlighted in the
work of Trivers and others on selﬁsh genetic elements
that facilitate their own transmission at the expense of
Evolutionary applications to medicine and public health Nesse and Stearns
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kins’ selﬁsh genes with a vengeance (Dawkins 1976). The
best known examples are the T-allele in mice and Segre-
gation Distorter in fruit ﬂies. The role of selﬁsh genetic
elements in human disease, including cancer (Crespi and
Summers 2005), is an especially exciting area that is start-
ing to be elucidated.
These advances also suggested looking for conﬂicts that
arise between genes transmitted through males versus
those transmitted through females. Following the lead of
Trivers (1974), Haig (1993) pointed out that in preg-
nancy, the interests of genes from the male differ from
those from the female. Genes derived from male beneﬁt if
they somehow induce the female to make more or larger
offspring. Energy reserves that a female mouse does not
invest in the current litter will not beneﬁt the male unless
he happens to mate with her again. Conversely, genes
from the female beneﬁt by reserving fat stores for future
reproduction. The size of offspring that maximally bene-
ﬁts the male is only slightly different from the size opti-
mal for the female, but this small difference may have
shaped a complex system. This evolutionary hypothesis is
supported by the details of a remarkable proximate mech-
anism.
Studies of genetically engineered mice show that the
unopposed expression of a gene called insulin-like growth
factor 2 (IGF2) results in a large placenta and large but
otherwise normal offspring; this outcome beneﬁts pater-
nal genes. When transmitted through the mother, this
gene is inactivated by a process called imprinting, making
the offspring smaller. IGF2r is a gene with opposite
effects; it degrades IGF. Its effect is decreased by imprint-
ing from passage through the father (Haig 1993). Loss of
IGF2 imprinting causes Beckwith–Wiedemann syndrome,
characterized by large babies with very large internal
organs. It may be more likely in offspring conceived using
artiﬁcial reproductive technologies (Maher et al. 2003).
This area of research vividly illustrates the clinical impli-
cations of studies that would never be considered without
sophisticated applications of evolutionary theory (Wilkins
and Haig 2003).
Addressing a much broader issue, it is worth noting
that ‘knock-out’ studies are about the evolutionary func-
tions of a gene. They are modern equivalents of the old
physiological method of extirpation. Taking out an organ
or a gene and looking to see what goes wrong can gener-
ate hypotheses about how an organ or gene is useful.
Often, no abnormality is observed. Of course, this does
not mean that the gene is useless, only that its effects are
covered by redundant systems, that its beneﬁts are mani-
fest only in special situations, or that the beneﬁt is just
too small to be observed in a laboratory setting. For
instance, genes involved the capacity for shivering might
well appear to be harmful, unless one happened to look
at their effects in extreme cold. Similarly, some genetic
variations associated with faster aging are likely to have
compensating advantages, otherwise they would have
been eliminated. As we are gaining technologies to
manipulate genes, evolutionary thinking about their ori-
gins and functions becomes more crucial than ever.
Aging research
Aging research shows how evolutionary thinking can
transform a ﬁeld. Many doctors still view aging as an inev-
itable result of body parts wearing out. This knowledge
gap is unfortunate for a trait so important to medicine.
Half a century ago, Medawar (1952) saw that selection
weakens with age because the surviving number of indi-
viduals declines, even in the absence of senescence. Then
Williams (1957) had the insight that pleiotropic genes that
cause aging and death can nonetheless be selected for if
they also give beneﬁts early in life when selection is stron-
ger. He gave a vivid hypothetical example of a gene that
makes bones heal faster in childhood, but that also slowly
deposits calcium in the coronary arteries. Hamilton
(1966) provided mathematical models for the process.
These evolutionary insights transformed aging research
(Finch 1991, 2007). Instead of looking only for proximate
explanations for aging, the ﬁeld now also seeks evolution-
ary explanations for why aging mechanisms exist at all.
Laboratory (Rose 1991; Stearns et al. 2000) and ﬁeld evi-
dence (Austad 2005) soon showed that aging was a life
history trait shaped by natural selection (Stearns 1992,
2000). For many species, senescence in the wild is a dele-
terious trait with heritable variation, but life spans do not
increase, presumably because the reproductive beneﬁts of
longer lives would be balanced by costs that decrease
reproduction earlier in the life span (Nesse 1988; Austad
2005; Williams et al. 2006).
The big new news in aging research is the discovery of
remarkably strong effects of single genes that inﬂuence
oxidative metabolism (Guarente and Kenyon 2000;
Austad 2005). These surprising ﬁndings are now being
interpreted in evolutionary terms (Partridge and Gems
2006; Ackermann and Pletcher 2007; McElwee et al.
2007). They suggest that mechanisms that protect against
oxidative damage are limited by their reproductive costs
or just lack of selection. They also show how selection
can shape special states of reduced metabolism that allow
some species to survive periods of privation. These states
slow aging dramatically, but they are special states
precisely because they also so dramatically reduce
reproduction. The ancient dream of extending lifespan no
longer seems like just a dream, but do not buy beach
property on Hudson Bay just yet.
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has long been known that men die younger than
women, but this has rarely been interpreted in a life-his-
tory framework. A recent report about higher mortality
rates for male than female mammals attributes it to
both external causes and faster aging. The faster rates of
aging for males are found mainly in polygynous species
because a shortened reproductive span decreases the
force of selection for older males (Clutton-Brock and
Isvaran 2007). An evolutionary view of humans sug-
gested looking at the ratio of male to female mortality
across the lifespan in different cultures. This found sur-
prising results (Kruger and Nesse 2004). In every culture
at every age through late adulthood, mortality rates are
higher for men. In modern societies, for every woman
who dies at reproductive maturity, three men die. The
pattern is consistent in 20 cultures studied. Further work
looking at the proximate causes of sex differences in
mortality rates ﬁnds that they result not only from acci-
dents and violence, but also from the full range of
causes of mortality.
Infectious disease
Applications of evolutionary biology to infectious disease
are also very direct. Pathogens evolve fast, right under
(and in!) our noses. Antibiotic resistance is the classic
example. Individual bacteria and viruses vary in their sus-
ceptibility to antimicrobial agents; those with even slight
resistance replicate faster and their genotypes become
more common. Just a few years after Alexander Fleming
discovered penicillin, he also discovered antibiotic resis-
tance. The basic phenomenon is very simple. Antibiotics
are selction agents that quickly increase the proportion of
organisms that can resist them. (Bergstrom and Feldgar-
den 2007).
Shortly after the US Surgeon General declared in the
mid-1950s that the war on infectious disease was over,
antibiotic resistance became a serious problem. Staphylo-
coccus quickly became resistant to penicillin, nearly all
other bacteria followed. Antibiotic resistance is an arms
race; we invent new defenses, the enemy quickly ﬁnds
ways around them, and we try to ﬁnd new defenses. We
are now faced with many organisms that resist every
available antibiotic; some wonder if the war on infec-
tious disease may be lost (Normark and Normark 2002;
Levy and Marshall 2004). Nearly 10% of Staphylococcus
aureus are now resistant even to methicillin; infections
caused by this resistant organism now cause 18 650
deaths per year, more than the 12 500 caused by AIDS
(Klevens et al. 2007). The economic burden of antibiotic
resistance is estimated at about $80 billion annually in
the USA.
Recognition of antibiotic resistance as an example of
natural selection is often missing in medical articles on the
topic. In biology journals the phrase ‘natural selection’ or
another direct reference to evolution is used 79.1% of the
time to describe antibiotic resistance, but in biomedical
journals they were used only 17.8% of the time. Instead,
medical journals use ‘emergence’ or some other circumlo-
cution to avoid the ‘E-word’ (Antonovics et al. 2007).
Many doctors view antibiotics as human discoveries,
but most are results of selection acting over millions of
years in the deadly interactions of bacteria and fungi with
each other. The average bacteria isolated from soil dem-
onstrates resistance to seven antibiotics (D’Costa et al.
2006). This is not because of exposure to human-pro-
duced chemicals, but because the long co-evolution of
bacteria and fungi has shaped toxins, defenses and new
toxins (Ewald 1994). Bacteria and fungi have been devel-
oping and testing the effectiveness of antibiotics for mil-
lions of years!
Another important aspect of resistance is whether it
has costs to the resistant bacteria that will select against
the resistance if antibiotics are withdrawn. The answer is
sometimes yes, but often the costs seem to be so low that
resistance persists, an ecological insight of huge impor-
tance for controlling antibiotic resistance (Andersson and
Levin 1999). Continuous application of antibiotics also
produces selection to reduce their costs, yielding resistant
strains that persist after the antibiotics are withdrawn
(Schrag and Perrot 1996). However, restriction of antibi-
otic use in Danish farm animals resulted in decreased
resistance (Aarestrup et al. 2001). More work on these
evolutionary responses is of great importance.
Selection on pathogens is, of course, not a one-way
street. Hosts evolve too, creating co-evolutionary cycles of
deception and ability to detect deception of vast complex-
ity (Ewald 1994; Knodler et al. 2001; Frank 2002). The
genes of vulnerable individuals become less common, and
host resistance evolve, but very slowly compared with the
rate of pathogen evolution.
Some of the resulting genetic change is in mechanisms
close to the sites of infectivity. For instance, malaria uses
the Duffy antigen to enter red blood cells. Individuals
without the Duffy antigen are less susceptible to malaria
and have a selective advantage where malaria is common
(Hamblin and Di Rienzo 2000). This is why the Duffy
antigen is absent in most Africans.
The CCR-5 receptor on white blood cells allows HIV
to enter. The receptor is absent in about 1% of Europe-
ans; they do not get AIDS even when infected with HIV
(Samson et al. 1996). Some geographical evidence sug-
gested that this genetic difference could result from
selection by the plague epidemic in the 14th century, but
in a nice example of hypothesis testing, more careful
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Weaver 2006). Would we all be better off without the CCR-
5 receptor? With the advent of HIV the answer may be yes,
but this receptor is not useless; at the very least it appears
to protect against West-Nile infection (Lim et al. 2006).
When a parasite such as malaria deals with both a
mosquito and a mammal host, the complexity of its evo-
lution is magniﬁed (Mackinnon and Read 2004; Grech
et al. 2006). Here host–parasite manipulations can be
studied in detail, and their complexity is more than
intriguing. Doctors learn about the complexity of parasite
life cycles, but rarely do they have an opportunity to con-
sider their evolutionary origins. Nor do they have the
evolutionary principles that would allow them to evaluate
proposals to drive genetically engineered strains of mos-
quitoes into wild populations. Such proposals rarely take
into account how the introduced strains will evolve in
interaction with the wild ones.
Changes in the phenotype also exert selection forces on
pathogens. Vaccination of large populations fundamen-
tally changes the environment for a pathogen. For
instance, steady pertussis vaccination for 40 years may
have selected for more virulent strains of the whooping
cough bacteria (Diavatopoulos et al. 2005), although
decreased vaccination may be responsible for the
increased incidence. Imperfect vaccines can create selec-
tion pressures for increased virulence (Gandon et al.
2001). This disturbing possibility has been documented
for Marek’s disease in chickens (Davison and Nair 2005).
However, when a vaccine targets a toxin, selection can
decrease virulence. This has happened for diphtheria,
where lines that do not produce toxin have largely dis-
placed the dangerous forms (Soubeyrand and Plotkin
2002). These ﬁndings have obvious major public health
implications, but the complex realities of host pathogen
interactions make conﬁdent prediction difﬁcult (Ebert
and Bull 2003).
Intuitive models for antibiotic resistance are often
incorrect (Normark and Normark 2002). For instance,
some hospitals have tried rotating the antibiotic of choice
over a period of a few months with the idea that by
exposing bacteria to changing selective regime, this will
prevent antibiotic resistance. But when the process is
modeled, this turns out that antibiotic rotation is ineffec-
tive at creating a more heterogeneous suite of selective
conditions. At least in principle, hospitals would do better
to use a mix of different drugs on different patients
simultaneously, rather than to cycle through these differ-
ent drugs over time (Bergstrom et al. 2004).
Perhaps equally important are more general but less-
recognized selection forces from infectious agents. We
have a wide variety of protective bodily responses, such as
fever, cough and vomiting, that are held in reserve until
released by a mechanism that detects the presence of
pathogens (Ewald 1994) Mechanisms that regulate expres-
sion of these defenses are under constant selection (Nesse
2005c). Individuals vary in how high fever rises during
infection, how quickly immune cells are activated, and
how much diarrhea is produced for a given level of infec-
tion. Most symptoms of infectious disease are not caused
directly by the pathogens: they result from these useful
defenses. Some are aspects of the inﬂammation and
immune systems that attack pathogens. Others, such as
cough, diarrhea and vomiting, extrude pathogens. For all
such defenses, one might think that selection would shape
regulation mechanisms to be close to the optimal.
But what is optimal? The answer is surprising. When
the cost of a false alarm is low relative to the possible
costs of not expressing a sufﬁcient defense when it is
needed, selection shapes regulation mechanisms that
express the defense more readily or more intensely than
seems sensible. We put up with smoke detectors that
sometimes wail when we make toast because we want to
be sure they warn us about any real ﬁre. The ‘smoke
detector principle,’ applies signal detection theory to yield
quantitative predictions about how selection shaped
defense regulation mechanisms (Nesse 2005c). It has clin-
ical relevance because so much everyday medicine
involves prescribing medications that block defenses such
as fever, pain and cough. This tends to be safe because
the body has redundant defense mechanisms and because
the thresholds for defense expression are set by the smoke
detection principle. Sometimes, however, it is fatal.
Far from suggesting that doctors should let nature take
its course, an evolutionary perspective suggests that many
defensive reactions are excessive or entirely unnecessary.
It also suggests that we have only begun to study a crucial
set of principles at the core of general medicine. General
practice could have a stronger foundation in science if
practitioners had tools for thinking about how selection
shaped defense regulation. Most already know that using
codeine to block cough after surgery is likely to result in
pneumonia, and an increasing number recognize the util-
ity of fever. However, only a few are thinking about how
natural selection shaped the mechanisms that regulate
defenses. Such thinking will lead to new studies that pro-
vide the evidence we need to make better clinical deci-
sions. In one particularly important example, a debate is
now underway about whether inﬂuenza kills people
directly or via the effects of released inﬂammatory agents
(Salomon et al. 2007). If the former is true, anti-inﬂam-
matory drugs will increase death rates, if the latter is true
it will decrease them.
The central defense against pathogens is, of course, the
immune system. The costs as well as the beneﬁts of
immune responses need to be analyzed in evolutionary
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iller and Deerenberg 2000; Zuk and Stoehr 2002; Schmid-
Hempel and Ebert 2003). In addition to energetic costs,
there is tissue damage from immune surveillance, repro-
ductive costs, mate display costs, and others. Of particular
interest is variation in immune response, either because
of limited resources or facultative systems that adapt the
response to the current inner and outer situation
(Schmid-Hempel 2003).
The study of pathogen virulence offers another example
of how an evolutionary perspective can transform a ﬁeld.
Just a decade ago, many physicians were taught that natu-
ral selection tended to shape pathogens and hosts to a
benign mutual co-existence. After all, why kill the host
that feeds you? Rigorous evolutionary analysis revealed
that this view is fundamentally incorrect (Anderson and
May 1979; May and Anderson 1979; Ewald 1994; Frank
1996; Ebert 1998).
The most important factor shaping virulence is its
inﬂuence on the probability of transmission to a new
host; virulence is shaped to whatever level maximizes
transmission. For instance, prior to modern sanitation,
bedridden patients with cholera could infect others and
the organisms causing the most diarrhea were transmitted
the most. The result is often fatal, but such traits are
nonetheless selected for if they maximize transmission.
This could have major implications for public health.
Good water puriﬁcation systems prevent infection from
bedridden patients, thus shifting the advantage to less vir-
ulent organisms whose victims can be up and around to
spread them.
Virulence levels can also be inﬂuenced when several
genetically different pathogen strains compete within a
host. This should select for increased virulence. Studies of
trypanosomiasis (sleeping sickness) suggest multiple infec-
tions may be much more common than previously sus-
pected (Balmer and Tostado 2006).
Developing applications
Much of the recent work in evolutionary medicine asks
questions about why natural selection has left the body
vulnerable to disease (Williams and Nesse 1991; Ewald
1994; Nesse and Williams 1994; Stearns 1998; Trevathan
et al. 1999). Six categories summarize the main possible
explanations: mismatch with the modern environment,
pathogens coevolving with hosts, constraints on what
selection can do, unavoidable trade-offs, reproduction at
the expense of health, and defenses such as pain and fever
that are useful despite causing suffering and complica-
tions (Nesse 2005b). These are potential evolutionary
explanations for why selection has not made the body
more resistant to disease. They are fundamentally differ-
ent from proximate explanations about how the body
works. The last two are not exactly explanations for dis-
ease vulnerability, but they need to be on the list because
they are so often the source of misunderstandings. Some
hypotheses can be tested with a deﬁnitive experiment,
others with comparative data, and some must be assessed
by comparing observed features to those expected given
the hypothesis (Nesse 2008). Like much in science, this
can be challenging.
Six reasons for vulnerability
Selection is slow
1. Mismatch with the modern environment
2. Pathogens coevolving with hosts
What selection can do is limited
3. Constraints on what selection can do
4. Trade-offs
We misunderstand what selection shapes
5. Selection maximizes reproduction, not health
6. Defenses such as pain and fever are useful despite causing suffer-
ing and complications
Nutrition and development
The ‘thrifty phenotype’ refers most generally to the bene-
ﬁts of weight gain and other mechanisms that conserve
calories in environments characterized by erratic nutrition
(Neel et al. 1998b). The extraordinary vulnerability to
obesity in certain groups, such as Pima Indians and
inhabitants of the South Paciﬁc island of Palau, has been
suggested to result from generations of experience with
erratic food supplies. Anthropological data on cultural
variations in nutritional stability do not well support this
interpretation (Benyshek and Watson 2006). However,
the more general idea that selection maximizes calorie
conservation remains useful.
Natural selection may also have shaped mechanisms
that adjust metabolic systems to cope with different nutri-
tional environments. Many studies demonstrate that low
birth weight is a signiﬁcant risk factor for obesity and
diabetes in diverse populations (Barker et al. 2002). The
evolutionary question is whether this ‘fetal programming’
is a ‘predictive adaptive response’ resulting from a mecha-
nism shaped by selection to monitor fetal nutrition and
adjust development in ways that facilitate coping with
deprivation (Gluckman et al. 2005), or whether the asso-
ciation arises for other reasons (Wells 2006).
Low birth weight is also correlated with differences in
stress reactivity (Clark 1997) and rates of depression
(Costello et al. 2007). The adaptive signiﬁcance of these
reactions is as hard to ﬁgure out as the reactions are
important. Whatever the answer turns out to be, these
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physiological state of mother and infant for the preva-
lence of lifestyle diseases later in life, with some well-doc-
umented effects delayed by several decades.
Miscarriage
Has natural selection shaped a mechanism to detect and
reject a fetus that is likely to succumb early to infection?
A surprising amount of evidence is consistent with this
hypothesis. The early term miscarriage rate is over 60%
(Boklage 1990), and siblings tend to be more different in
their HLA immunological types than expected by chance.
This suggests that other conceptions who received similar
HLA genes from both parents may have been selectively
lost (Ober et al. 1998). While giving up a conception is
inefﬁcient, continuing to support a fetus who will likely
succumb to infection is even more so, thus creating a
selection force that could shape such a system. Related
evidence shows that spouses in small local communities
tend to have HLA types more different than expected
(Ober et al. 1997). Pheromone cues may guide individu-
als towards mates who differ sufﬁciently from themselves
(Jacob et al. 2002). That the human female reproductive
tract has been shaped to screen defective gametes and
concepti is now well supported. That humans detect and
choose mates based on immune complementarity is sug-
gested by several studies but not yet deﬁnitively con-
ﬁrmed (Loisel et al. 2007).
Hygiene hypothesis
The huge decreases in human mortality in the past cen-
tury come not mainly from medical treatments, but from
public health interventions, vaccination and sanitation in
particular (Armstrong et al. 1999). They have, together,
done more than all of the rest of medicine to improve
human health. They also have created an environment
vastly different from the one we evolved in.
One result is a decreased burden of parasites such as
worms in the gut. During most of human evolution we
lived with helminth parasites. Their absence in modern
societies may help explain the vastly increased rates of
autoimmune diseases, not just allergies, but diabetes and
the childhood leukemias (Elliott et al. 2007). Regulation
systems, including those that screen for antigens that
react with self, were shaped with signiﬁcant helminth
loads on board (Weinstock et al. 2004). New evidence
suggests that helminths evolved a capacity to make a pro-
tein (ES-62) that down-regulates Type-II immunity that
would otherwise attack them (Melendez et al. 2007).
Where helminth treatment has been initiated, asthma and
Crohn’s disease rates have gone up (Hurtado in press).
The cross reactivity between antibodies on schistosomes
and dust mites, and different genetic levels of protection
against helminths, may help to explain higher rates of
asthma in people of African origins (Barnes 2006).
In a bold clinical application, patients with an immune
bowel disease, Crohn’s disease, were treated with the live
ova of pig whipworm. About 70% entered remission
(Summers et al. 2005). We can expect fast progress in
autoimmune disease thanks to improved evolutionary
understanding of the rule of modern hygiene.
Cancer
Evolutionary approaches to cancer in general have pro-
gressed so quickly that their scope can only be suggested
here (Greaves 2000, 2002). The very existence of cancer
results from an evolutionary process: differential replica-
tion of mutated cells (Merlo et al. 2006). The constant
tendency for faster replicating cells to displace others is
rigidly controlled by systems that regulate cell division
and by surveillance systems that kill cells that are not
where they belong. The length of telomeres, the bits of
DNA that hang from the end of chromosomes, may pro-
tect against cancer. Each time a cell divides, the telomere
get shorter; when it is gone, the cell dies. However, there
is a side effect. Short telomeres also shorten life-span
(Blasco 2005). Mathematical treatments of genes that pre-
dispose to cancer (Crespi and Summers 2006) and cancer
cell evolution (Frank 2007) offer promise of bringing
coherence to this difﬁcult ﬁeld.
Epidemiology
The greatest opportunities for evolutionary applications
relevant to health may be in public health and epidemiol-
ogy. Many have already been mentioned above, from diet
to genetic epidemiology. Every project needs an individu-
alized application, but a few generalizations may help. For
instance, when looking for risk factors for common dis-
eases, the ﬁrst question is whether the condition is equally
common in hunter–gatherer populations. If not, then
novel factors in the modern environment should top our
list of suspects. Some already do, such as too much fat
and too little exercise. Other factors, like the hygiene
hypothesis mentioned above, are increasingly well sup-
ported. Other apparently innocuous aspects of the mod-
ern environment deserve special attention.
For instance, ubiquitous lighting has transformed our
lives. Instead of settling down to slow pursuits when
darkness falls, we read, study, dance and watch television
until long after we would have otherwise gone to sleep.
The light itself may be risky. Melatonin levels increase in
the dark. A study of visually impaired women – who tend
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of breast cancer about half of the rates for other women
(Kliukiene et al. 2001). A subsequent study of nurses
found those doing shift work and others exposed to light
at night had increased cancer rates (Stevens 2005). In a
ﬁne demonstration of the value of research connecting
proximate mechanisms with evolutionary hypotheses,
melatonin-depleted blood from postmenopausal women
has been shown to speed the growth of human breast
cancer xenografts on nude mice (Blask et al. 2005). More
work is needed on this, but even now it suggests a new
set of risk factors we should measure, and some simple
public health advice – sleep with the lights off.
Obesity has doubled in the past 40 years in the USA,
so that two-thirds of adults are now overweight or obese
(Wang and Beydoun 2007). Diabetes and obesity are
strongly correlated (Neel et al. 1998a). About 194 million
adults worldwide have diabetes, and Type 2 diabetes (late
onset) is exploding. Most diabetic patients are in India
and China, and diabetes rates are expected to double,
from 171 million in 2000 to 366 million in 2030 (Wild
et al. 2004). Much of the individual difference in vulnera-
bility is accounted for by genetic differences (Echwald
1999), but this does not mean the obesity epidemic
results from genetic abnormalities. Instead, it means that
novel aspects of our modern environment interact with
genetic quirks to cause the problem, as it the case for
nearly every polygenic disease. While not all ancestral
environments were alike (Elton in press), it does seem
clear that modern diets are vastly different from almost
everything that came before.
We know what we should do to stay thin. We should
eat less and exercise more. So, why don’t we? One answer
is that in the past individuals who were thin or who
wasted calories in nonproductive exercise tended to have
fewer children. Selection favored those who took advan-
tage of opportunities to eat fat, salt and sugar and who
stored some extra calories in good times. Selection has
shaped mechanisms that limit weight gain, but they are
feeble compared with those that prevent weight loss.
These arguments have been made many times (Eaton
and Konner 1985; Eaton et al. 2002; Chakravarthy and
Booth 2004), but nutrition researchers sometimes still see
these evolutionary hypotheses as alternatives rather than
complements to new insights about molecular and physi-
ological mechanisms that regulate caloric intake.
An evolutionary view suggests two conclusions about
diet, both unwelcome. First, most of us have built in
tendencies to overeat and under-exercise when good
food is available without much effort. Second, there is
no such thing as a completely natural diet that is per-
fectly safe. Eating less fat is certainly wise, but it has
costs. A diet of all wild vegetables will include poten-
tially toxic substances. Nonetheless, evolution does offer
a way to ground the otherwise faddish area of nutrition
research in a solid general understanding of the diets
of our ancestors (Eaton et al. 2002; Leonard 2007;
Ungar 2007).
Mental disorders
Evolutionary principles are just beginning to be applied
to mental disorders (Nesse 1984, 2005a; Wenegrat 1990;
Baron-Cohen 1997; McGuire and Troisi 1998; Badcock
and Crespi 2006), and they promise to bring them into
the fold with other medical disorders (Nesse 1999). Per-
haps paradoxically, this may ﬁnally happen by recognizing
the utility of negative emotions such as anxiety and
depression (Gilbert 1998; Nesse 2000).
About half of mental disorders are emotional disorders
characterized by excesses of negative emotions. While
there is no doubt that much anxiety and depression is
pathological, the capacities for anxiety and depression
were shaped by natural selection along with the mecha-
nisms that regulate them. These disorders are not like
diabetes or Parkinson’s disease where a speciﬁc pathologi-
cal lesion causes the disease. They are, instead, more like
chronic pain or chronic cough, where the problem is dys-
regulation of a response that can be normal and useful.
Recognition that such evolutionary explanations are
needed in addition to proximate explanations of mecha-
nisms is just now dawning, along with recognition that
categorical diagnoses that take no cognizance of environ-
mental factors are fundamentally mistaken (Nesse and
Jackson 2006; Wakeﬁeld and Horwitz 2007).
Genes interact with environmental factors to create
mental disorders. For instance, a study of a serotonin-
related polymorphism found that its strong effects on
depression vulnerability were almost all mediated via an
interaction with the number of severe life events (Caspi
et al. 2003). This has become an exemplar for studies of
gene · environment interactions. However, the measure
of environmental effects, the number of severe life events,
is crude compared with the sophistication of genetic anal-
yses, especially in light of growing knowledge that low
mood can be useful in certain special life circumstances
(Brown et al. 1995; Nesse 2000; Heckhausen et al. 2001).
There are good theoretical reasons for thinking that low
mood escalates to depression when an unreachable major
life goal cannot be given up, and some supporting labora-
tory data (Carver and Scheier 1990), but the case has not
yet been proved.
Disorders such as schizophrenia require fundamentally
different explanations. Older ideas about the adaptive
value of schizophrenia are now mostly discredited,
although a haplotype associated with higher IQ is also
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Lindenberg et al. 2007). Also, a haplotype associated with
a GABA-A receptor shows clear signs of positive selection,
which are weaker in lineages with schizophrenia (Lo et al.
2007). Of particular interest is the hypothesis that autism
and schizophrenia may be the ﬂip-sides of extremes of
the competition between imprinted genes coming from
the father and the mother, the Haig idea applied to psy-
chiatry (Badcock and Crespi 2006; Crespi et al. 2007).
Substance abuse is both more straightforward and
more difﬁcult. The straightforward aspect is that most
drugs that affect the central nervous system evolved in
plants to protect them from insects. In modern environ-
ments we create increasingly clever ways of purifying and
administering them making addiction more common and
more devastating. They hijack brain mechanisms that
evolved to regulate behaviors such as foraging for ripe
nuts (Nesse and Berridge 1997). The problem becomes
quickly complex, however, because of profound individ-
ual genetic variations in vulnerability to substance abuse
that interact in complex ways with social environments
that vary even from month to month for individuals
(Zucker 2006). The ﬁeld in general is gradually moving
from an exclusive focus on proximate mechanisms and
individual differences, to a broader consideration of the
origins of vulnerabilities humans share and how they
interact with certain environments to create disease.
Conclusions
This review supports a global conclusion: much interest-
ing and important research is taking place at the intersec-
tion of evolution and medicine. This research ranges
from well-established applications of population genetics
and phylogeny to new applications of evolution to spe-
ciﬁc medical problems such as infectious disease and
aging. Work in the area is growing rapidly.
The fastest growth is in two disparate areas. First are
those where evolution helps to make sense of new genetic
data. Why, for example, do genes that predispose to
asthma persist? Who would have thought they protect
against schistosomes? Growth is also fast in research ask-
ing new questions about why selection has left the body
vulnerable to speciﬁc diseases. Why, for instance, does
bilirubin exist? Who would have thought it was to slow
aging?
Another question is whether evolution and medicine is
one ﬁeld, or is it just a collection of applications of differ-
ent aspects of evolutionary theory? The increasing num-
ber of books and conferences that cover the full range of
applications has found a large and eager audience. These
initiatives have brought together diverse scientists and cli-
nicians who are often delighted to learn about each
other’s work. In their shared evolutionary foundations,
anthropologists, geneticists, physiologists, mathematical
modelers and parasitologists turn out to have much in
common. This is not artiﬁcial interdisciplinarity; advances
in understanding evolution illuminate all of these ﬁelds
and research in each of these ﬁelds offers opportunities
for advancing evolutionary biology.
The structure of evolutionary medicine is still deﬁned
mainly by the different contributing disciplines. Genetics,
paleontology, microbiology and immunology, ecology,
reproductive medicine, cancer research, physiology, anat-
omy, behavioral biology, epidemiology, anthropology, and
clinical medicine – all pursue evolutionary questions
using somewhat different traditions and methods. A new
framework, perhaps one based on questions such as those
in the Table in the Introduction, may emerge. For now,
the important observation is that workers in different
ﬁeld are increasingly ﬁnding commonalities in their
shared foundation: evolutionary biology.
Awkward tensions always lurk when scientists from
diverse disciplines come together. Those working at more
reductionist levels, sometimes pull away from those work-
ing on higher level questions. Some doctors are uncom-
fortable welcoming in another discipline they do not
know well. Some evolutionary biologists grow quickly
impatient with doctors who do not already know all
about evolutionary biology. Whether this new ﬁeld can
avoid such fragmentation remains to be seen, but many
research opportunities provide a unifying force. For
instance, research on lactase persistence beneﬁts markedly
from close collaboration between geneticists and anthro-
pologists, and their conclusions have clinical relevance.
A related challenge is dealing with hypotheses about
adaptation (Rose and Lauder 1996). Experimental meth-
ods are not often available, many scientists are unfamiliar
with comparative and other methods, ﬁrm conclusions
can be elusive, and standards of evidence are still evolving
(Nesse 2008). Editors do not always have access to evolu-
tionary expertise, so some good work does not get pub-
lished where it will be widely seen, and some iffy ideas
get presented as stronger than they are. While these prob-
lems are not universal, they are real, and they will be
solved only by doing science – proposing hypotheses,
testing them, discarding those that fail, coming up with
new ideas, and ﬁnding better ways to test them.
The boundary between basic science and applied medi-
cine offers another challenge. Preparing this review has
impressed us with the number of clinically relevant ﬁnd-
ings. However, does understanding evolution change dra-
matically what a physician does in her day-to-day work?
In general it does not, and should not. Clinical decisions
based on theory alone are notoriously suspect. Treatment
should, whenever possible, be based on controlled studies
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understanding among physicians fosters misunderstanding
about issues as important as aging, diet, and when it is
wise to use medications to block defensive responses.
While there is a trend for doctors to just carry out proto-
cols, we want doctors to have a deep knowledge base so
their decisions are informed by understanding the body
and disease. Better decisions come from doctors who
understand the ecology of immune responses, the evolu-
tionary reasons for polygenic diseases, the phylogeny of
cancer cells, and the origins of antibiotics.
We began by describing the magnitude of the gulf
between evolutionary biology and medicine. We were
struck by how much work is now transcending the gap,
but we also were surprised to discover that the gap is
even larger than we had thought. The research results
described in this article are but a small ﬂock of birds ﬂy-
ing over the Grand Canyon.
Does it matter? Would efforts to bridge the gap pay off
in improved human health? Many of the ﬁndings
reviewed here suggest the answer is yes. They serve at the
very least to suggest new studies, ranging from whether
we need to be concerned about vaccines causing increased
virulence to what kinds of disorders are likely to arise
from advanced reproductive technologies.
However, even aside from suggesting studies with
direct clinical and public health relevance, evolutionary
approaches increase our fundamental understanding of
the body and disease. This is basic science at its most
basic. The huge investments in understanding the mech-
anisms of the cell and gene replication dwarf all invest-
ments to date in understanding the evolutionary origins
and functions of traits that leave us vulnerable to dis-
ease. We predict that increased focus on evolutionary
questions will not only offer useful new understanding,
it will also synergize with new understanding of mecha-
nisms.
In the Abstract, we suggested that an evolutionary pers-
pective will be especially helpful in doing away with the
incorrect metaphor of the body as a machine designed by
an engineer. Some readers certainly wondered what we
could possibly mean. Of course, the body is a machine in
the sense that it is composed of chemicals, levers, pulleys
and systems that maintain homeostasis. Furthermore,
machines and bodies are alike in one important way; both
are bundles of trade-offs. Improving any one trait will
likely harm something else.
However, because they are products of evolution,
bodies are very different from machines (Childs 1999). A
deep understanding of the body as a body is perhaps evo-
lution’s greatest single contribution to medicine.
Machines are designed by an engineer to serve a human
purpose. Blueprints deﬁne the ideal type, and manufac-
turing attempts to turn out identical units. When a defect
is discovered, engineers change the design.
Bodies are not designed; they are shaped by natural
selection. There is no blueprint, no ideal type. Variation
is intrinsic. There is no normal genome. There is no nor-
mal body. There is no separate manufacturing facility;
there is just the process of development – genes interact-
ing with environments to create adult forms. The process
involves some chance factors, and also adaptations that
monitor the early environment and shift development in
ways that adjust the adult form to a particular environ-
ment. Some traits, such as a birth canal that passes
through a narrow circle of bone, cause problems for the
species. But there is no engineer with a drawing board to
go back to. Rerouting birth via the abdominal wall would
work better, but the intermediate stages between that
and the current route would not work, so the system
stays suboptimal. Bodies are bodies shaped by selection,
not machines designed by intelligence. Giving up the
machine metaphor gives medicine a stronger foundation
in biology.
Practical suggestions
Finally, there is the challenge of how best to advance
work at the interface of evolutionary biology and medi-
cine. We offer the following brief observations and sug-
gestions in hopes that they will stir discussion and action.
Building a scientiﬁc community
At present there is no way to ﬁnd out what is going on
in the ﬁeld of evolution and medicine. No keywords ade-
quately capture the literature; there is no journal and no
society. The resources at The Evolution and Medicine
Network (http://EvolutionAndMedicine.org) offer access
to a variety of teaching and information resources and a
nucleus for the growing community. The Network is
being expanded to include The Evolution and Medicine
Review: news, recent publications of interest, commentar-
ies on the most notable papers, and questions posed and
answered by members of the community. It is intended
to meet the need for a central source of information
about new research and opportunities in this diverse ﬁeld.
Evolutionary Applications is a natural outlet for new
research in the area of evolution and medicine, and a spe-
cial issue devoted to the topic is planned for 2009.
Discussions are underway to organize a society for evo-
lution and medicine. The International Alliance of
Research Universities (IARU) Evolutionary Medicine Ini-
tiative has budgeted funds for a founding meeting in
2009, likely in conjunction with the Darwin Festival cele-
brations honoring the 200th year of Darwin’s birth and
the 150th anniversary of the publication of The Origin of
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updated information on this and other new develop-
ments.
Specialized research training
Many young scientists and physicians want to apply evo-
lutionary principles in their areas of medical research, but
training programs are not yet available. Some are being
organized. A proposal to be funded by the IARU will pro-
vide research training in evolutionary medicine at six uni-
versities including the University of Copenhagen, which is
recruiting a professor of evolutionary medicine. Several
other universities, including Durham in the UK, are also
developing programs. A major research institute is not
yet in the works.
Many have suggested pursuing the strategy that worked
so well in the early days of human genetics, summer
workshops that bring together established and junior
researchers for an intense period of study and discussion
with leaders in the basic science. The Evolution and Med-
icine Network will announce such programs as they
become available.
Research funding
Funding for projects in evolutionary medicine is available
for aging, genetics, and infectious disease. The NIH
Genetic Variation and Evolution Study Section has been
especially valuable not only in providing funding, but also
in providing guidance that increases the quality of work
in this subﬁeld. Support for work on broader questions is
harder to ﬁnd. Private foundations can take the lead in
supporting important projects that do not ﬁt the portfo-
lio of government funding agencies, and in supporting
efforts to develop the ﬁeld as a whole.
Medical education reforms
We say reforms, because physicians not now taught even
the most basic principles of evolutionary biology as they
apply to medicine. It is as if the engineering curriculum
included no physics. With no evolutionary biologists on
their faculties, no resources to hire them, and an overly-full
curriculum, only a very occasional far-sighted dean and
faculty will be able to bring evolutionary biology into the
curriculum. The modernization of medical education will
be helped by curriculum recommendations from advisory
bodies such as the Institute of Medicine that are backed up
by new questions on tests administered by the National
Board of Medical Examiners and other similar bodies.
While some aspects of evolutionary biology must be a
part of medical education, it is unrealistic to provide all
of the necessary foundations in medical school. Like other
basic knowledge, much needs to be in courses prior to
medical training. Undergraduate courses on evolutionary
medicine are an excellent solution. Most such courses do
not provide enough basic evolutionary knowledge, so a
combination with a basic evolution course is essential.
The logical outcome will be evolutionary questions on the
examinations like the MCATS in the USA that are used
to screen applicants to medical schools.
Implementation of the above recommendations will
require close collaborations among physicians, medical
researchers, and basic scientists. Creating such connec-
tions tends to be difﬁcult because rigid administrative
barriers separate the units at most universities, leaving
them ill-suited to take advantage of major opportunities
such as those at the interface of evolution and medicine.
Fortunately, however, the barriers are products of human
institutions not natural selection. Human intelligence and
foresight can change those institutions and make action
plans that will bring the full power of evolutionary biol-
ogy to bear on problems of human health.
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